PDX通过P38 MAPK通路促进脓毒症性ARDS抗菌肽cathelicidin表达

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (1694 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To explore the effect of PDX on the expression of cathelicidin antimicrobial peptide in sepsis-induced ARDS and the possible signaling pathway. Methods: C57BL/6 mice underwent cecal ligation and puncture to establish the sepsis model. Mice were divided as: Sham group, CLP group, CLP+PDX group, CLP+PDX+SB203580 group, CLP+PDX+DMSO group and PDX group. HE staining was used to evaluate the lung injury situation, CFU was used to detect the colony forming situation. The expression of cathelicidin antimicrobial peptide gene in lung tissue was detected by qPCR. Western blot was used to detect the expression of CAMP and the activation of P38 MAPK and ERK MAPK pathway. Results: Compared with Sham group, ERK MAPK pathway showed no significant change in the CLP group, while P38 MAPK pathway was significantly inhibited (P<0.05), and CAMP expression increased distinctly (P<0.05); compared with the CLP group, mice in the CLP+PDX group had less hemorrhage, inflammtory cell infiltration in lung tissue, decreased obviously CFU while the activation of P38 MAPK and the expression of cathelicidin antimicrobial peptide increased significantly (P<0.05). Conclusion: PDX increased the expression of cathelicidin antimicrobial peptide via P38 MAPK pathway in sepsis-induced ARDS.

Key words： sepsis PDX MAPK antimicrobial peptide cathelicidin

Received: 10 February 2019

	Service
	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	GU Lijun
	PAN Jingyi
	Mohamed Ali Abdullahi
	JIN Shengwei

URL:

https://xb.wmu.edu.cn/EN/ OR https://xb.wmu.edu.cn/EN/Y2019/V49/I7/469

[1] Alcayaga-Miranda F, Cuenca J, Khoury M. Antimicrobial activity of mesenchymal stem cells: current status and new perspectives of antimicrobial peptide-based therapies[J]. Front Immunol, 2017, 8: 339.
[2] Li Y, Xiang Q, Zhang Q, et al. Overview on the recent study of antimicrobial peptides: Origins, functions, relative mechanisms and application[J]. Peptides, 2012, 37(2): 207-215.
[3] Schauber J, Gallo R L. Antimicrobial peptides and the skin immune defense system[J]. J Allergy Clin Immunol, 2009, 124(3 Suppl 2): R13-18.
[4] BUCKLEY C D, GILROY D W, SERHAN C N, et al. The resolution of inflammation[J]. Nat Rev Immunol, 2013, 13(1): 59-66.
[5] Buckley C D, Gilroy D W, Serhan C N. Proresolving lipid mediators and mechanisms in the resolution of acute inflam-mation[J]. Immunity, 2014, 40(3): 315-327.
[6] SERHAN C N. Pro-resolving lipid mediators are leads for resolution physiology[J]. Nature, 2014, 510(7503): 92-101.
[7] Li H, Hao Y, Zhang H, et al. Posttreatment with Protectin DX ameliorates bleomycin-induced pulmonary fibrosis and lung dysfunction in mice[J]. Sci Rep, 2017, 7: 46754.
[8] Jung T W, Kim H C, Abd El-Aty A M, et al. Protectin DX ameliorates palmitate-or high-fat diet-induced insulin resistance and inflammation through an AMPK-PPARα-dependent pathway in mice[J]. Sci Rep, 2017, 7(1): 1397.
[9] Jung T W, Chung Y H, Kim H C, et al. Protectin DX attenuates LPS-induced inflammation and insulin resistance in adipocytes via AMPK-mediated suppression of the NFκB pathway[J]. Am J Physiol Endocrinol Metab, 2018, 315(4): E543-E551.
[10] Morishima I, Yamano Y, Inoue K, et al. Eicosanoids mediate induction of immune genes in the fat body of the silkworm, Bombyx mori[J]. FEBS Lett, 1997, 419(1): 83-86.
[11] Canny G, Levy O, Furuta G T, et al. Lipid mediator-induced expression of bactericidal/permeability-increasing protein (BPI) in human mucosal epithelia[J]. Proc Natl Acad Sci U S A, 2002, 99(6): 3902-3907.
[12] Campbell E L, MacManus C F, Kominsky D J,
et al. Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxifi-cation[J]. Proc Natl Acad Sci U S A, 2010, 107(32): 14298-14303.
[13] Dejager L, Pinheiro I, Dejonckheere E, et al. Cecal ligation and puncture: the gold standard model for polymicrobial sepsis?[J]. Trends Microbiol, 2011, 19(4): 198-208.
[14] Lyons M M, Raj N N, Chittams J L, et al. TAT-HSP70 attenuates experimental lung injury[J]. Shock, 2015, 43(6): 582-588.
[15] Perl M, Lomas-Neira J, Venet F, et al. Pathogenesis of indirect (secondary) acute lung injury[J]. Expert Rev Respir Med, 2011, 5(1): 115-126.
[16] Taranu I, Marin D E, Braicu C, et al. In vitro transcriptome response to a mixture of lactobacillistrains in intestinal porcine epithelial cell line[J]. Int J Mol Sci, 2018, 19(7). pii: E1923.
[17] JOSEPH S, YUEN A, SINGH V, et al. Mycobacterium tuberculosis Cpn60.2 (GroEL2) blocks macrophage apoptosis via interaction with mitochondrial mortalin[J]. Biol Open, 2017, 6(4): 481-488.
[18] Sun L, Wang W, Xiao W, et al. The roles of cathelicidin LL-37 in inflammatory bowel disease[J]. Inflamm Bowel Dis, 2016, 22(8): 1986-1991.
[19] Hwang H J, Jung T W, Kim J W, et al. Protectin DX prevents H2O2-mediated oxidative stress in vascular endothelial cells via an AMPK-dependent mechanism[J]. Cell Signal, 2019, 53: 14-21.
[20] XIA H, CHEN L, LIU H, et al. Protectin DX increases survival in a mouse model of sepsis by ameliorating inflammation and modulating macrophage phenotype[J]. Sci Rep, 2017, 7(1): 99.
[21] Kusaka S, Nishida A, Takahashi K, et al. Expression of human cathelicidin peptide LL-37 in inflammatory bowel disease[J]. Clin Exp Immunol, 2017, 191(1): 96-106.
[22] YANG R, YANG E, SHEN L, et al. IL-12+IL-18 cosignaling in human macrophages and lung epithelial cells activates cathelicidin and autophagy, inhibiting intracellular mycobacterial growth[J]. J Immunol, 2018, 200(7): 2405-2417.
[23] JIAO D, WONG C K, TSANG M S, et al. Activation of eosinophils interacting with bronchial epithelial cells by antimicrobial peptide LL-37: implications in allergic asthma[J]. Sci Rep, 2017, 7(1): 1848.
[24] Park K, Elias P M, Oda Y, et al. Regulation of cathelicidin antimicrobial peptide expression by an endoplasmic reticulum (ER) stress signaling, vitamin D receptor-independent pathway[J]. J Biol Chem, 2011, 286(39): 34121-34130.